D-0543-2025 Class II Ongoing

Recalled by FDC Limited — Aurangabad, Maharashtra State

FDA drug recall D-0543-2025 was initiated by FDC Limited on Jul 5, 2025 and is designated Class II. Reason for recall: Defective Container: spike of the cap becomes lodged in the nozzle of the product bottle. The recall status is ongoing. Affected quantity: 154,176 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 6, 2025
Initiation Date
Jul 5, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
154,176 bottles

Product description

Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, NDC 64980-514-05.

Reason for recall

Defective Container: spike of the cap becomes lodged in the nozzle of the product bottle.

Distribution pattern

U.S Nationwide.

Code information

Lot#: 083L061, Exp.: 11/2025.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0543-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0543-2025. Report a data issue: hello@regdatalab.com.